These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis. Hijnen DJ, ten Berge O, Timmer-de Mik L, Bruijnzeel-Koomen CA, de Bruin-Weller MS. J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):85-9. PubMed ID: 17207173 [Abstract] [Full Text] [Related]
4. Cyclosporine A in atopic dermatitis. Gaig P, Alijotas J, López A, Valencia M, Cisteró A. Allergol Immunopathol (Madr); 1993 Jan; 21(5):169-72. PubMed ID: 8160560 [Abstract] [Full Text] [Related]
5. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema. Zoller L, Ramon M, Bergman R. Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134 [Abstract] [Full Text] [Related]
6. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis. Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K. J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179 [Abstract] [Full Text] [Related]
9. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis. Singalavanija S, Noppakun N, Limpongsanuruk W, Wisuthsarewong W, Aunhachoke K, Chunharas A, Wananukul S, Akaraphanth R. J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874 [Abstract] [Full Text] [Related]
10. A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life. Czech W, Bräutigam M, Weidinger G, Schöpf E. J Am Acad Dermatol; 2000 Apr; 42(4):653-9. PubMed ID: 10727313 [Abstract] [Full Text] [Related]
11. [Cyclosporin in atopic dermatitis]. Pacor ML, Biasi D, Di Lorenzo G, Carletto A, Corrocher R. Recenti Prog Med; 2001 Jun; 92(6):390-1. PubMed ID: 11433717 [Abstract] [Full Text] [Related]
12. [Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life]. Sunderkötter C, Weiss JM, Bextermöller R, Löffler H, Schneider D. J Dtsch Dermatol Ges; 2006 Apr; 4(4):301-6. PubMed ID: 16638059 [Abstract] [Full Text] [Related]
13. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. Paller AS, Eichenfield LF, Kirsner RS, Shull T, Jaracz E, Simpson EL, US Tacrolimus Ointment Study Group. Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204 [Abstract] [Full Text] [Related]
14. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis]. de Bruin-Weller MS, Bruijnzeel-Koomen CA. Ned Tijdschr Geneeskd; 2005 May 14; 149(20):1096-100. PubMed ID: 15932135 [Abstract] [Full Text] [Related]
15. [Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology]. Gliński W, Kruszewski J, Silny W, Kurzawa R, Czarnecka-Operacz M, Baran E, Szepietowski J, Task Force of the National Specialists on Dermatology, Venereology and Allergology. Pol Merkur Lekarski; 2004 May 14; 17 Suppl 3():3-15. PubMed ID: 15688665 [Abstract] [Full Text] [Related]
16. Severe atopic dermatitis treated with everolimus. Van Velsen SG, Haeck IM, Bruijnzeel-Koomen CA. J Dermatolog Treat; 2009 May 14; 20(6):365-7. PubMed ID: 19954394 [Abstract] [Full Text] [Related]
17. [The practice guideline 'atopic dermatitis']. Bruijnzeel-Koomen CA, Sillevis Smitt JH, Boukes FS, van Everdingen JJ. Ned Tijdschr Geneeskd; 2007 Jun 23; 151(25):1399-402. PubMed ID: 17668603 [Abstract] [Full Text] [Related]
18. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). Eberlein B, Eicke C, Reinhardt HW, Ring J. J Eur Acad Dermatol Venereol; 2008 Jan 23; 22(1):73-82. PubMed ID: 18181976 [Abstract] [Full Text] [Related]
19. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study. van Velsen SG, Haeck IM, Bruijnzeel-Koomen CA, de Bruin-Weller MS. Br J Dermatol; 2009 Mar 23; 160(3):687-91. PubMed ID: 19120337 [Abstract] [Full Text] [Related]